ARTICLE | Company News
MorphoSys, Novartis antibody deal
May 19, 2004 7:00 AM UTC
The companies will use MorphoSys' Human Combinatorial Antibody Library (HuCAL-GOLD) to identify therapeutic antibodies against targets specified by Novartis (NVS; SWX:NOVN). NVS will also have access ...